TCRT (Alaunos Therapeutics) Kacepetan wutah bathi saben saham ing taun lumaku

Lambang korporat lan logo Alaunos Therapeutics (TCRT)

Alaunos Therapeutics (TCRT) generates revenue by granting usage rights for the Sleeping Beauty system to develop oncology drugs. The annual earnings per share trend clearly demonstrates current dynamics, where 0.00 determines the current value of the metric. While the company relies on a closed ecosystem for non-viral lymphocyte modification, a prolonged crisis and workforce reductions make the business's survival dependent on the sale of patents.

TCRT: Wutah bathi saben saham ing taun lumaku Alaunos Therapeutics Inc. 04.07.2022 - 16.11.2026

Rincian metrik keuangan lan pasar Alaunos Therapeutics Inc. (TCRT)

Pambiji fundamental:TCRT alaunos.com
Produk sing diprodhuksi Alaunos Therapeutics, Inc.

The deep crisis at Alaunos Therapeutics (TCRT), triggered by workforce reductions and program halts, makes business survival dependent on patent licensing. EPS YoY dynamics measure the year-over-year percentage change in earnings per share, reflecting the efficiency of value generation per share. Analyzing EPS YoY volatility allows for the verification of the downturn phase and determines whether the current bottom will serve as a reversal point or a precursor to asset degradation.